Literature DB >> 11316271

Functional integrity of the vesicle transporting machinery is required for complete activation of cFTR expressed in xenopus laevis oocytes.

W M Weber1, A Segal, J Simaels, A Vankeerberghen, J J Cassiman, W Van Driessche.   

Abstract

We expressed the human cystic fibrosis transmembrane conductance regulator (CFTR) in oocytes of the South African clawed frog Xenopus laevis. We performed simultaneous and continuous recording of membrane current (Im), conductance (Gm) and capacitance (Cm), the latter being a direct measure of membrane surface area. A cAMP-cocktail containing cAMP and isobutylmethylxanthine (IBMX) increased all parameters, demonstrating that CFTR activation was partly achieved by exocytotic delivery and insertion of preformed CFTR molecules into the plasma membrane. CFTR currents after cAMP-cocktail were correlated with the capacitance of the oocytes: oocytes with larger Cm exhibited larger currents. Expression of CFTR itself did not change the Cm of the oocytes. However, activation of CFTR with cAMP-cocktail increased Im and Gm 15- and 20-fold, respectively while membrane surface area increased by about 7%, indicating the functional insertion of preformed CFTR into the plasma membrane. While cAMP-cocktail yielded maximal CFTR stimulation, IBMX alone, but not caffeine or theophylline, was sufficient to stimulate more than half of the increases in Im and Gm as observed with cAMP-cocktail. Since Cm was not significantly stimulated by IBMX, we conclude that IBMX alone activated the CFTR channels already present in the oocyte membrane. CFTR stimulation by cAMP-cocktail was independent of external Ca2+ and ATP had no additional activating potency. The role of protein trafficking in the activation of CFTR evoked by increases of cytoplasmic cAMP was assessed by measuring the effects of brefeldin A (BFA), nocodazole and primaquine on the bioelectric parameters and membrane surface area. All these compounds that interfere with the protein trafficking machinery at different stages prevented the translocation of CFTR from intracellular pools to the plasma membrane. These data confirm and extend our previous observations that CFTR expressed in Xenopus laevis oocytes is activated via dual pathways including direct activation of CFTR already present in the membrane and exocytotic insertion of preformed CFTR channels into the membrane. Furthermore, we show that complete activation of CFTR requires an intact protein trafficking machinery.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11316271     DOI: 10.1007/s004240000497

Source DB:  PubMed          Journal:  Pflugers Arch        ISSN: 0031-6768            Impact factor:   3.657


  5 in total

1.  Contribution of casein kinase 2 and spleen tyrosine kinase to CFTR trafficking and protein kinase A-induced activity.

Authors:  Simão Luz; Patthara Kongsuphol; Ana Isabel Mendes; Francisco Romeiras; Marisa Sousa; Rainer Schreiber; Paulo Matos; Peter Jordan; Anil Mehta; Margarida D Amaral; Karl Kunzelmann; Carlos M Farinha
Journal:  Mol Cell Biol       Date:  2011-09-19       Impact factor: 4.272

2.  Zinc is a voltage-dependent blocker of native and heterologously expressed epithelial Na+ channels.

Authors:  Bogdan Amuzescu; Andrei Segal; Maria-Luiza Flonta; Jeannine Simaels; Willy Van Driessche
Journal:  Pflugers Arch       Date:  2003-02-12       Impact factor: 3.657

3.  CFTR channel in oocytes from Xenopus laevis and its regulation by xShroom1 protein.

Authors:  Alejandra G Palma; Luciano Galizia; Basilio A Kotsias; Gabriela I Marino
Journal:  Pflugers Arch       Date:  2016-02-18       Impact factor: 3.657

Review 4.  Imaging CFTR in its native environment.

Authors:  Hermann Schillers
Journal:  Pflugers Arch       Date:  2007-12-05       Impact factor: 3.657

5.  Functional interaction between CFTR and the sodium-phosphate co-transport type 2a in Xenopus laevis oocytes.

Authors:  Naziha Bakouh; Baya Chérif-Zahar; Philippe Hulin; Dominique Prié; Gérard Friedlander; Aleksander Edelman; Gabrielle Planelles
Journal:  PLoS One       Date:  2012-04-13       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.